Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online November 13, 2007
Diabetes Care 31:311-315, 2008
DOI: 10.2337/dc07-1593
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1593v1
31/2/311    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jani, R.
Right arrow Articles by Abdul-Ghani, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jani, R.
Right arrow Articles by Abdul-Ghani, M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Research

Decreased Non–Insulin-Dependent Glucose Clearance Contributes to the Rise in Fasting Plasma Glucose in the Nondiabetic Range

Rucha Jani, MD, Marjorie Molina, MD, Masafumi Matsuda, MD, Bogdan Balas, MD, Alberto Chavez, MD, Ralph A. DeFronzo, MD and Muhammad Abdul-Ghani, MD, PHD

From the Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas

Address correspondence and reprint requests to Muhammad Abdul-Ghani, MD, PhD, University of Texas Health Science Center at San Antonio, Diabetes Division, 7703 Floyd Curl Dr., San Antonio, TX 78229. E-mail: albarado{at}uthscsa.edu

OBJECTIVE—To assess the contribution of decreased glucose clearance to the rise in fasting plasma glucose (FPG) in the nondiabetic range.

RESEARCH DESIGN AND METHODS—A total of 120 subjects with normal glucose tolerance received an oral glucose tolerance test and euglycemic insulin clamp with 3-[3H]glucose. The basal and insulin-stimulated rates of glucose appearance, glucose disappearance, and glucose clearance and the basal hepatic insulin resistance index were calculated. Simple Pearson's correlation was used to assess the relationship between variables.

RESULTS—The increase in FPG (range 75–125 mg/dl) correlated (r = 0.32, P < 0.0001) with the increase in BMI (20–50 kg/m2). The fasting plasma insulin (FPI) concentration also increased progressively with the increase in BMI (r = 0.62, P < 0.0001). However, despite increasing FPI, the basal glucose clearance rate declined and correlated with the increase in BMI (r = –0.56, P < 0.0001). Basal hepatic glucose production (HGP) decreased with increasing BMI (r = –0.51, P < 0.0001) and correlated inversely with the increase in FPI (r = –0.32, P < 0.0001). The hepatic insulin resistance (basal HGP x FPI) increased with rising BMI (r = 0.52, P < 0.0001). During the insulin clamp, glucose disposal declined with increasing BMI (r = –0.64, P < 0.0001) and correlated with the basal glucose clearance (r = 0.39, P < 0.0001).

CONCLUSIONS—These results demonstrate that in nondiabetic subjects, rising FPG is associated with a decrease (not an increase) in basal hepatic glucose production and is explained by a reduction in glucose clearance.

Abbreviations: FPG, fasting plasma glucose • FPI, fasting plasma insulin • HGP, hepatic glucose production • OGTT, oral glucose tolerance test


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.